Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920504's PB Ratio is ranked worse than 70.52% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.14
vs BJSE:920504: 3.57
During the past 12 months, Shanghai Boxun Medical Biological Instrument's average Book Value Per Share Growth Rate was 6.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 17.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 17.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Boxun Medical Biological Instrument was 23.20% per year. The lowest was -1.50% per year. And the median was 12.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai Boxun Medical Biological Instrument PB Ratio Related Terms
Shanghai Boxun Medical Biological Instrument PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument PB Ratio Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument PB Ratio vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a PB Ratio of 3.57 as of Aug. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 18% below median its historical median of 4.34. Over the past decade, Shanghai Boxun Medical Biological Instrument's PB Ratio has ranged from 1.78 to 6.94. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #555 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 70.5%.
Is Shanghai Boxun Medical Biological Instrument's PB Ratio too high?
Shanghai Boxun Medical Biological Instrument's current PB Ratio of 3.57 is 18% below median its 10-year median of 4.34. Over the past 10 years, this metric has ranged from a low of 1.78 to a high of 6.94. The Medical Devices & Instruments industry median PB Ratio is 2.14. Shanghai Boxun Medical Biological Instrument's value of 3.57 is 66.8% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #555 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #555 out of 787 companies for PB Ratio. This places Shanghai Boxun Medical Biological Instrument in the lower half of its industry. The industry median PB Ratio is 2.14. Shanghai Boxun Medical Biological Instrument's value of 3.57 is 66.8% above this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own PB Ratio has ranged from 1.78 to 6.94 over the past decade. While the company's 10-year median is 4.34 vs. the industry median of 2.14, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.14, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current PB Ratio of 3.57 is 66.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current PB Ratio is 3.57, which is 18% below median its own 10-year median of 4.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current PB Ratio is 3.57, which is 18% below median its 10-year median of 4.34 and 66.8% above the Medical Devices & Instruments industry median of 2.14. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current PB Ratio is 3.57 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
PB Ratio: 3.57 (18% below median its 10-year median of 4.34)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 66.8% above the Medical Devices & Instruments median (#555 of 787)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
